Investments
39Portfolio Exits
7About Ariel Savannah Angel Partners
Ariel Savannah Angel Partners (ASAP) is a member-driven angel investment group which invests in early-stage high-growth potential companies. ASAP members are accredited individual investors who actively participate in reviewing investment opportunities and work on member teams to conduct due diligence on selected opportunities. The group invests primarily in Georgia, South Carolina and the Southeast region.
Ariel Savannah Angel Partners Headquarters Location
Savannah, Georgia,
United States
Latest Ariel Savannah Angel Partners News
May 10, 2021
Kern Venture Group led a $765,000 Series Seed round for Mill It. Ariel Savannah Angel Partners, alongside investors from the Santa Barbara Angel Alliance and Tech Coast Angels, filled out the remainder of the round. Mill It is a plant-based company that makes dairy alternative products by using ancient grains. Through a proprietary fermentation method, Mill It has developed the first plant-based buttermilk which it plans to use to create several new plant-based products and offerings including its salad dressings. (c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.
Ariel Savannah Angel Partners Investments
39 Investments
Ariel Savannah Angel Partners has made 39 investments. Their latest investment was in New View Surgical as part of their Series B on September 9, 2021.
Ariel Savannah Angel Partners Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
9/16/2021 | Series B | New View Surgical | $9M | Yes | 2 | |
9/8/2015 | Unattributed VC - III | Cognition Therapeutics | $12M | Yes | 1 | |
12/20/2013 | Bridge | Avaxia Biologics | $2.87M | No | 1 | |
6/7/2013 | Series B - II | |||||
5/2/2013 | Angel - IV |
Date | 9/16/2021 | 9/8/2015 | 12/20/2013 | 6/7/2013 | 5/2/2013 |
|---|---|---|---|---|---|
Round | Series B | Unattributed VC - III | Bridge | Series B - II | Angel - IV |
Company | New View Surgical | Cognition Therapeutics | Avaxia Biologics | ||
Amount | $9M | $12M | $2.87M | ||
New? | Yes | Yes | No | ||
Co-Investors | |||||
Sources | 2 | 1 | 1 |
Ariel Savannah Angel Partners Portfolio Exits
7 Portfolio Exits
Ariel Savannah Angel Partners has 7 portfolio exits. Their latest portfolio exit was Respiratory Motion on June 01, 2022.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
6/1/2022 | Acquired | 3 | |||
Date | 6/1/2022 | ||||
|---|---|---|---|---|---|
Exit | Acquired | ||||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 3 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.